Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AXSM

Axsome Therapeutics

$5.95

0.25 (4.39%)

07:13
08/09/17
08/09
07:13
08/09/17
07:13
Earnings
Breaking Earnings news story on Axsome Therapeutics »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXSM

Axsome Therapeutics

08:29
07/26/17
07/26
08:29
07/26/17
08:29
Recommendations
Axsome Therapeutics analyst commentary at Ladenburg »

Axsome Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXSM

Axsome Therapeutics

$5.70

0.1 (1.79%)

07:09
07/25/17
07/25
07:09
07/25/17
07:09
Hot Stocks
Axsome Therapeutics says AXS-06 Phase 1 clinical trial met primary endpoint »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXSM

Axsome Therapeutics

$5.95

-0.05 (-0.83%)

07:11
07/17/17
07/17
07:11
07/17/17
07:11
Hot Stocks
Axsome Therapeutics initiates Phase 2/3 trial of AXS-05 »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXSM

Axsome Therapeutics

$5.15

-0.15 (-2.83%)

07:05
07/06/17
07/06
07:05
07/06/17
07:05
Hot Stocks
Axsome Therapeutics appoints John Golubieski »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Over a quarter ago
AXSM

Axsome Therapeutics

$3.80

0.05 (1.33%)

08:28
05/19/17
05/19
08:28
05/19/17
08:28
Initiation
Axsome Therapeutics initiated at BTIG »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$4.20

0.3 (7.69%)

07:34
05/09/17
05/09
07:34
05/09/17
07:34
Earnings
Axsome Therapeutics reports Q1 EPS (41c), consensus (39c) »

As of March 31 Axsome had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$3.90

0.05 (1.30%)

08:28
05/08/17
05/08
08:28
05/08/17
08:28
Technical Analysis
Axsome Therapeutics up sharply on FDA fast track designation for AXS-05 »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$3.90

0.05 (1.30%)

07:14
05/08/17
05/08
07:14
05/08/17
07:14
Hot Stocks
Axsome Therapeutics receives FDA fast track designation for AXS-05 »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$4.05

0.05 (1.25%)

15:21
04/27/17
04/27
15:21
04/27/17
15:21
Hot Stocks
Breaking Hot Stocks news story on Axsome Therapeutics »

Laurence W. Lytton…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.